Correction: Evidence of Blood Stage Efficacy with a Virosomal Malaria Vaccine in a Phase IIa Clinical Trial.

Eitemau Tebyg

• Evidence of Blood Stage Efficacy with a Virosomal Malaria Vaccine in a Phase IIa Clinical Trial
  gan: Thompson, Fiona M., et al.
  Cyhoeddwyd: (2008)
• Correction: Evidence of Blood Stage Efficacy with a Virosomal Malaria Vaccine in a Phase IIa Clinical Trial
  gan: Thompson, Fiona M., et al.
  Cyhoeddwyd: (2011)
• A Randomized Placebo-Controlled Phase Ia Malaria Vaccine Trial of Two Virosome-Formulated Synthetic Peptides in Healthy Adult Volunteers
  gan: Genton, Blaise, et al.
  Cyhoeddwyd: (2007)
• Design and pre-clinical profiling of a Plasmodium falciparum MSP-3 derived component for a multi-valent virosomal malaria vaccine
  gan: Tamborrini, Marco, et al.
  Cyhoeddwyd: (2009)
• Immunogenicity of a virosomally-formulated <it>Plasmodium falciparum </it>GLURP-MSP3 chimeric protein-based malaria vaccine candidate in comparison to adjuvanted formulations
  gan: Tamborrini Marco, et al.
  Cyhoeddwyd: (2011-12-01)